Viewing Study NCT00933361


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2025-12-30 @ 5:56 PM
Study NCT ID: NCT00933361
Status: COMPLETED
Last Update Posted: 2017-08-01
First Post: 2009-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Sponsor: Cantonal Hospital of St. Gallen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module